Molecular regulators of pubertal mammary gland development

References

• Howard BA, Gusterson BA. Human breast development. Mammary Gland Biol Neoplasia. 2000;5:119–37.
   PubMed Web of Science ®Google Scholar
• Ingman WV, Robertson SA. Mammary gland development in transforming growth factor beta1 null mutant mice: systemic and epithelial effects. Biol Reprod. 2008; 79:711–7.
   PubMedGoogle Scholar
• Atwood CS, Hovey RC, Glover JP, Chepko G, Ginsburg E, Robison WG, . Progesterone induces side-branching of the ductal epithelium in the mammary glands of peripubertal mice. J Endocrinol. 2000;167:39–52.
   Google Scholar
• Sternlicht MD, Kouros-Mehr H, Lu P, Werb Z. Hormonal and local control of mammary branching morphogenesis. Differentiation. 2006;74:365–81.
   PubMed Web of Science ®Google Scholar
• Silberstein GB, Strickland P, Coleman S, Daniel CW. Epithelium-dependent extracellular matrix synthesis in transforming growth factor-beta 1-growth-inhibited mouse mammary gland. J Cell Biol. 1990;110:2209–19.
   PubMed Web of Science ®Google Scholar
• Topper YJ, Freeman CS. Multiple hormone interactions in the developmental biology of the mammary gland. Physiol Rev. 1980;60:1049–56.
   PubMed Web of Science ®Google Scholar
• LaMarca HL, Rosen JM. Minireview: hormones and mammary cell fate—what will I become when I grow up? Endocrinology. 2008;149:4317–21.
   Google Scholar
• Brisken C. Hormonal control of alveolar development and its implications for breast carcinogenesis. J Mammary Gland Biol Neoplasia. 2002;7:39–48.
   PubMedGoogle Scholar
• Daniel CW, Silberstein GB, Strickland P. Direct action of 17 beta-estradiol on mouse mammary ducts analyzed by sustained release implants and steroid autoradiography. Cancer Res. 1987;47:6052–7.
   PubMed Web of Science ®Google Scholar
• Deroo BJ, Hewitt SC, Collins JB, Grissom SF, Hamilton KJ, Korach KS. Profile of estrogen-responsive genes in an estrogen-specific mammary gland outgrowth model. Mol Reprod Dev. 2009;76:733–50.
   PubMed Web of Science ®Google Scholar
• Couse JF, Korach KS. Estrogen receptor null mice: what have we learned and where will they lead us? Endocr Rev. 1999;20:358–417.
   PubMed Web of Science ®Google Scholar
• Bocchinfuso WP, Korach KS. Mammary gland development and tumorigenesis in estrogen receptor knockout mice. J Mammary Gland Biol Neoplasia. 1997;2:323–34.
   PubMed Web of Science ®Google Scholar
• Mallepell S, Krust A, Chambon P, Brisken C. Paracrine signaling through the epithelial estrogen receptor alpha is required for proliferation and morphogenesis in the mammary gland. Proc Natl Acad Sci U S A. 2006;103: 2196–201.
   PubMed Web of Science ®Google Scholar
• Han SJ, DeMayo FJ, Xu J, Tsai SY, Tsai MJ, O'Malley BW. Steroid receptor coactivator (SRC)-1 and SRC-3 differentially modulate tissue-specific activation functions of the progesterone receptor. Mol Endocrinol. 2006;20:45–55.
   PubMed Web of Science ®Google Scholar
• Howlin J, McBryan J, Martin F. Pubertal mammary gland development: insights from mouse models. J Mammary Gland Biol Neoplasia. 2006;11:283–97.
   PubMed Web of Science ®Google Scholar
• Howlin J, McBryan J, Napoletano S, Lambe T, McArdle E, Shioda T, . CITED1 homozygous null mice display aberrant pubertal mammary ductal morphogenesis. Oncogene. 2006;25:1532–42.
   PubMedGoogle Scholar
• Nikolova Z, Djonov V, Zuercher G, Andres AC, Ziemiecki A. Cell-type specific and estrogen dependent expression of the receptor tyrosine kinase EphB4 and its ligand ephrin-B2 during mammary gland morphogenesis. J Cell Sci. 1998;111(Pt 18):2741–51.
   Google Scholar
• Munarini N, Jager R, Abderhalden S, Zuercher G, Rohrbach V, Loercher S, . Altered mammary epithelial development, pattern formation and involution in transgenic mice expressing the EphB4 receptor tyrosine kinase. J Cell Sci. 2002;115(Pt 1):25–37.
   Google Scholar
• LaMarca HL, Rosen JM. Estrogen regulation of mammary gland development and breast cancer: amphiregulin takes center stage. Breast Cancer Res. 2007;9:304.
   Google Scholar
• Ciarloni L, Mallepell S, Brisken C. Amphiregulin is an essential mediator of estrogen receptor alpha function in mammary gland development. Proc Natl Acad Sci U S A. 2007;104:5455–60.
   PubMedGoogle Scholar
• Lee S, Medina D, Tsimelzon A, Mohsin SK, Mao S, Wu Y, . Alterations of gene expression in the development of early hyperplastic precursors of breast cancer. Am J Pathol. 2007;171:252–62.
   Google Scholar
• Johnston SR. Clinical efforts to combine endocrine agents with targeted therapies against epidermal growth factor receptor/human epidermal growth factor receptor 2 and mammalian target of rapamycin in breast cancer. Clin Cancer Res. 2006;12(3 Pt 2):1061s–8s.
   Google Scholar
• Shyamala G, Yang X, Silberstein G, Barcellos-Hoff MH, Dale E. Transgenic mice carrying an imbalance in the native ratio of A to B forms of progesterone receptor exhibit developmental abnormalities in mammary glands. Proc Natl Acad Sci U S A. 1998;95:696–701.
   PubMed Web of Science ®Google Scholar
• Hovey RC, Trott JF, Ginsburg E, Goldhar A, Sasaki MM, Fountain SJ, . Transcriptional and spatiotemporal regulation of prolactin receptor mRNA and cooperativity with progesterone receptor function during ductal branch growth in the mammary gland. Dev Dyn. 2001;222: 192–205.
   Google Scholar
• Schneider W, Ramachandran C, Satyaswaroop PG, Shyamala G. Murine progesterone receptor exists predominantly as the 83-kilodalton ‘A’ form. J Steroid Biochem Mol Biol. 1991;38:285–91.
   PubMedGoogle Scholar
• Conneely OM, Mulac-Jericevic B, Lydon JP, De Mayo FJ. Reproductive functions of the progesterone receptor isoforms: lessons from knock-out mice. Mol Cell Endocrinol. 2001;179:97–103.
   PubMed Web of Science ®Google Scholar
• Brisken C, Park S, Vass T, Lydon JP, O'Malley BW, Weinberg RA. A paracrine role for the epithelial progesterone receptor in mammary gland development. Proc Natl Acad Sci U S A. 1998 28;95:5076–81.
   PubMed Web of Science ®Google Scholar
• Humphreys RC, Lydon JP, O'Malley BW, Rosen JM. Use of PRKO mice to study the role of progesterone in mammary gland development. J Mammary Gland Biol Neoplasia. 1997;2:343–54.
   Google Scholar
• Lewis AA, Gomez ET, Turner CW. Mammary gland development with mammogen I in the castrated and the hypophysectomized rat. Endocrinology. 1942;30:37–47
   Google Scholar
• Reece RP, Turner CW, Hill RT. Mammary gland development in the hypophysectomized albino rat. Proc Soc Exp Biol Med. 1936;34:204–217.
   Google Scholar
• Ihle JN. STATs: signal transducers and activators of transcription. Cell. 1996;84:331–4.
   PubMed Web of Science ®Google Scholar
• Gallego MI, Binart N, Robinson GW, Okagaki R, Coschigano KT, Perry J, . Prolactin, growth hormone, and epidermal growth factor activate Stat5 in different compartments of mammary tissue and exert different and overlapping developmental effects. Dev Biol. 2001;229: 163–75.
   PubMed Web of Science ®Google Scholar
• Zhou Y, He L, Kopchick JJ. An exon encoding the mouse growth hormone binding protein (mGHBP) carboxy terminus is located between exon 7 and 8 of the mouse growth hormone receptor gene. Receptor. 1994;4:223–7.
   Google Scholar
• Zhou Y, Xu BC, Maheshwari HG, He L, Reed M, Lozykowski M, . A mammalian model for Laron syndrome produced by targeted disruption of the mouse growth hormone receptor/binding protein gene (the Laron mouse). Proc Natl Acad Sci U S A. 1997;94:13215–20.
   PubMed Web of Science ®Google Scholar
• Horseman ND, Zhao W, Montecino-Rodriguez E, Tanaka M, Nakashima K, Engle SJ, . Defective mammopoiesis, but normal hematopoiesis, in mice with a targeted disruption of the prolactin gene. EMBO J. 1997;16:6926–35.
   PubMed Web of Science ®Google Scholar
• Brisken C, Kaur S, Chavarria TE, Binart N, Sutherland RL, Weinberg RA, . Prolactin controls mammary gland development via direct and indirect mechanisms. Dev Biol. 1999;210:96–106.
   PubMed Web of Science ®Google Scholar
• Ormandy CJ, Binart N, Kelly PA. Mammary gland development in prolactin receptor knockout mice. J Mammary Gland Biol Neoplasia. 1997;2:355–64.
   PubMed Web of Science ®Google Scholar
• Santos SJ, Haslam SZ, Conrad SE. Signal transducer and activator of transcription 5a mediates mammary ductal branching and proliferation in the nulliparous mouse. Endocrinology. 2010;151:2876–85.
   Google Scholar
• Sebastian J, Richards RG, Walker MP, Wiesen JF, Werb Z, Derynck R, . Activation and function of the epidermal growth factor receptor and erbB-2 during mammary gland morphogenesis. Cell Growth Differ. 1998;9:777–85.
   PubMedGoogle Scholar
• Coleman S, Silberstein GB, Daniel CW. Ductal morphogenesis in the mouse mammary gland: evidence supporting a role for epidermal growth factor. Dev Biol. 1988;127:304–15.
   PubMedGoogle Scholar
• Kenney NJ, Smith GH, Rosenberg K, Cutler ML, Dickson RB. Induction of ductal morphogenesis and lobular hyperplasia by amphiregulin in the mouse mammary gland. Cell Growth Differ. 1996;7(1):1769–81.
   Google Scholar
• Luetteke NC, Qiu TH, Fenton SE, Troyer KL, Riedel RF, Chang A, . Targeted inactivation of the EGF and amphiregulin genes reveals distinct roles for EGF receptor ligands in mouse mammary gland development. Development. 1999;126:2739–50.
   PubMed Web of Science ®Google Scholar
• Sternlicht MD, Sunnarborg SW, Kouros-Mehr H, Yu Y, Lee DC, Werb Z. Mammary ductal morphogenesis requires paracrine activation of stromal EGFR via ADAM17-dependent shedding of epithelial amphiregulin. Development. 2005;132: 3923–33.
   PubMed Web of Science ®Google Scholar
• Jackson-Fisher AJ, Bellinger G, Ramabhadran R, Morris JK, Lee KF, Stern DF. ErbB2 is required for ductal morphogenesis of the mammary gland. Proc Natl Acad Sci U S A. 2004;101:17138–43.
   Google Scholar
• Muraoka-Cook RS, Feng SM, Strunk KE, Earp HS 3rd. ErbB4/HER4: role in mammary gland development, differentiation and growth inhibition. J Mammary Gland Biol Neoplasia. 2008;13:235–46.
   Google Scholar
• Jones FE, Jerry DJ, Guarino BC, Andrews GC, Stern DF. Heregulin induces in vivo proliferation and differentiation of mammary epithelium into secretory lobuloalveoli. Cell Growth Differ. 1996;7:1031–8.
   PubMedGoogle Scholar
• Qu S, Rinehart C, Wu HH, Wang SE, Carter B, Xin H, . Gene targeting of ErbB3 using a Cre-mediated unidirectional DNA inversion strategy. Genesis. 2006;44:477–86.
   Google Scholar
• Jackson-Fisher AJ, Bellinger G, Breindel JL, Tavassoli FA, Booth CJ, Duong JK, . ErbB3 is required for ductal morphogenesis in the mouse mammary gland. Breast Cancer Res. 2008;10:R96.
   Web of Science ®Google Scholar
• Schroeder JA, Lee DC. Dynamic expression and activation of ERBB receptors in the developing mouse mammary gland. Cell Growth Differ. 1998;9:451–64.
   PubMedGoogle Scholar
• Tidcombe H, Jackson-Fisher A, Mathers K, Stern DF, Gassmann M, Golding JP. Neural and mammary gland defects in ErbB4 knockout mice genetically rescued from embryonic lethality. Proc Natl Acad Sci U S A. 2003;100:8281–6.
   PubMed Web of Science ®Google Scholar
• Richert MM, Wood TL. The insulin-like growth factors (IGF) and IGF type I receptor during postnatal growth of the murine mammary gland: sites of messenger ribonucleic acid expression and potential functions. Endocrinology. 1999;140:454–61.
   Google Scholar
• Wood TL, Richert MM, Stull MA, Allar MA. The insulin-like growth factors (IGFs) and IGF binding proteins in postnatal development of murine mammary glands. J Mammary Gland Biol Neoplasia. 2000;5:31–42.
   Google Scholar
• Liu JL, LeRoith D. Insulin-like growth factor I is essential for postnatal growth in response to growth hormone. Endocrinology. 1999;140:5178–84.
   PubMed Web of Science ®Google Scholar
• Ruan W, Kleinberg DL. Insulin-like growth factor I is essential for terminal end bud formation and ductal morphogenesis during mammary development. Endocrinology. 1999; 140:5075–81.
   PubMed Web of Science ®Google Scholar
• Richards RG, Klotz DM, Walker MP, Diaugustine RP. Mammary gland branching morphogenesis is diminished in mice with a deficiency of insulin-like growth factor-I (IGF-I), but not in mice with a liver-specific deletion of IGF-I. Endocrinology. 2004;145:3106–10.
   Google Scholar
• Hadsell DL, Bonnette SG. IGF and insulin action in the mammary gland: lessons from transgenic and knockout models. J Mammary Gland Biol Neoplasia. 2000;5:19–30.
   PubMed Web of Science ®Google Scholar
• de Ostrovich KK, Lambertz I, Colby JK, Tian J, Rundhaug JE, Johnston D, . Paracrine overexpression of insulin-like growth factor-1 enhances mammary tumorigenesis in vivo. Am J Pathol. 2008;173:824–34.
   PubMedGoogle Scholar
• Loladze AV, Stull MA, Rowzee AM, Demarco J, Lantry JH 3rd, Rosen CJ, . Epithelial-specific and stage-specific functions of insulin-like growth factor-I during postnatal mammary development. Endocrinology. 2006;147:5412–23.
   Google Scholar
• Rowzee AM, Lazzarino DA, Rota L, Sun Z, Wood TL. IGF ligand and receptor regulation of mammary development. J Mammary Gland Biol Neoplasia. 2008;13:361–70.
   Google Scholar
• Lee AV, Weng CN, Jackson JG, Yee D. Activation of estrogen receptor-mediated gene transcription by IGF-I in human breast cancer cells. J Endocrinol. 1997;152:39–47.
   PubMed Web of Science ®Google Scholar
• Kato S, Endoh H, Masuhiro Y, Kitamoto T, Uchiyama S, Sasaki H, . Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase. Science. 1995;270:1491–4.
   PubMed Web of Science ®Google Scholar
• Lee AV, Yee D. Insulin-like growth factors and breast cancer. Biomed Pharmacother. 1995;49:415–21.
   PubMed Web of Science ®Google Scholar
• Ignar-Trowbridge DM, Pimentel M, Parker MG, McLachlan JA, Korach KS. Peptide growth factor cross-talk with the estrogen receptor requires the A/B domain and occurs independently of protein kinase C or estradiol. Endocrinology. 1996;137:1735–44.
   PubMed Web of Science ®Google Scholar
• Frasca F, Pandini G, Scalia P, Sciacca L, Mineo R, Costantino A, . Insulin receptor isoform A, a newly recognized, high-affinity insulin-like growth factor II receptor in fetal and cancer cells. Mol Cellular Biol. 1999;19:3278–88.
   PubMed Web of Science ®Google Scholar
• Brisken C, Ayyannan A, Nguyen C, Heineman A, Reinhardt F, Tan J, . IGF-2 is a mediator of prolactin-induced morphogenesis in the breast. Dev Cell. 2002;3:877–87.
   PubMed Web of Science ®Google Scholar
• Hovey RC, Harris J, Hadsell DL, Lee AV, Ormandy CJ, Vonderhaar BK. Local insulin-like growth factor-II mediates prolactin-induced mammary gland development. Mol Endocrinol. 2003;17:460–71.
   PubMedGoogle Scholar
• Flint DJ, Tonner E, Beattie J, Allan GJ. Role of insulin-like growth factor binding proteins in mammary gland development. J Mammary Gland Biol Neoplasia. 2008;13:443–53.
   Google Scholar
• Schwertfeger KL. Fibroblast growth factors in development and cancer: insights from the mammary and prostate glands. Curr Drug Targets. 2009;10:632–44.
   PubMedGoogle Scholar
• Coleman-Krnacik S, Rosen JM. Differential temporal and spatial gene expression of fibroblast growth factor family members during mouse mammary gland development. Mol Endocrinol. 1994;8:218–29.
   PubMedGoogle Scholar
• Imagawa W, Cunha GR, Young P, Nandi S. Keratinocyte growth factor and acidic fibroblast growth factor are mitogens for primary cultures of mammary epithelium. Biochem Biophys Res Commun. 1994;204:1165–9.
   Google Scholar
• Ewald AJ, Brenot A, Duong M, Chan BS, Werb Z. Collective epithelial migration and cell rearrangements drive mammary branching morphogenesis. Dev Cell. 2008;14:570–81.
   PubMed Web of Science ®Google Scholar
• Guo L, Degenstein L, Fuchs E. Keratinocyte growth factor is required for hair development but not for wound healing. Genes Dev. 1996;10:165–75.
   PubMed Web of Science ®Google Scholar
• Luo Y, Lu W, Mohamedali KA, Jang JH, Jones RB, Gabriel JL, . The glycine box: a determinant of specificity for fibroblast growth factor. Biochemistry. 1998;37:16506–15.
   PubMed Web of Science ®Google Scholar
• Wilson SE, Weng J, Chwang EL, Gollahon L, Leitch AM, Shay JW. Hepatocyte growth factor (HGF), keratinocyte growth factor (KGF), and their receptors in human breast cells and tissues: alternative receptors. Cell Mol Biol Res. 1994;40:337–50.
   Google Scholar
• Pedchenko VK, Imagawa W. Pattern of expression of the KGF receptor and its ligands KGF and FGF-10 during postnatal mouse mammary gland development. Mol Reprod Dev. 2000;56:441–7.
   Google Scholar
• Sekine K, Ohuchi H, Fujiwara M, Yamasaki M, Yoshizawa T, Sato T, . Fgf10 is essential for limb and lung formation. Nat Genet. 1999;21:138–41.
   PubMed Web of Science ®Google Scholar
• Watson CJ, Khaled WT. Mammary development in the embryo and adult: a journey of morphogenesis and commitment. Development. 2008;135:995–1003.
   Google Scholar
• Silberstein GB, Daniel CW. Reversible inhibition of mammary gland growth by transforming growth factor-beta. Science. 1987;237:291–3.
   PubMedGoogle Scholar
• Daniel CW, Silberstein GB, Van Horn K, Strickland P, Robinson S. TGF-beta 1-induced inhibition of mouse mammary ductal growth: developmental specificity and characterization. Dev Biol. 1989;135:20–30.
   PubMed Web of Science ®Google Scholar
• Robinson SD, Silberstein GB, Roberts AB, Flanders KC, Daniel CW. Regulated expression and growth inhibitory effects of transforming growth factor-beta isoforms in mouse mammary gland development. Development. 1991;113:867–78.
   PubMedGoogle Scholar
• Barcellos-Hoff MH, Ewan KB. Transforming growth factor-beta and breast cancer: Mammary gland development. Breast Cancer Res. 2000;2:92–9.
   Google Scholar
• Ewan KB, Shyamala G, Ravani SA, Tang Y, Akhurst R, Wakefield L, . Latent transforming growth factor-beta activation in mammary gland: regulation by ovarian hormones affects ductal and alveolar proliferation. Am J Pathol. 2002;160:2081–93.
   PubMed Web of Science ®Google Scholar
• Pierce DF Jr, Johnson MD, Matsui Y, Robinson SD, Gold LI, Purchio AF, . Inhibition of mammary duct development but not alveolar outgrowth during pregnancy in transgenic mice expressing active TGF-beta 1. Genes Dev. 1993;7:2308–17.
   PubMed Web of Science ®Google Scholar
• Snedeker SM, Brown CF, DiAugustine RP. Expression and functional properties of transforming growth factor alpha and epidermal growth factor during mouse mammary gland ductal morphogenesis. Proc Natl Acad Sci U S A. 1991;88: 276–80.
   PubMed Web of Science ®Google Scholar
• Kenney NJ, Huang RP, Johnson GR, Wu JX, Okamura D, Matheny W, . Detection and location of amphiregulin and Cripto-1 expression in the developing postnatal mouse mammary gland. Mol Reprod Dev. 1995;41:277–86.
   PubMed Web of Science ®Google Scholar
• Ingman WV, Robertson SA. The essential roles of TGFB1 in reproduction. Cytokine Growth Factor Rev. 2009;20:233–9.
   Google Scholar
• Silberstein GB, Flanders KC, Roberts AB, Daniel CW. Regulation of mammary morphogenesis: evidence for extracellular matrix-mediated inhibition of ductal budding by transforming growth factor-beta 1. Dev Biol. 1992;152:354–62.
   PubMed Web of Science ®Google Scholar
• Klinowska TC, Soriano JV, Edwards GM, Oliver JM, Valentijn AJ, Montesano R, . Laminin and beta1 integrins are crucial for normal mammary gland development in the mouse. Dev Biol. 1999;215:13–32.
   PubMedGoogle Scholar
• Daniel CW, Strickland P, Friedmann Y. Expression and functional role of E- and P-cadherins in mouse mammary ductal morphogenesis and growth. Dev Biol. 1995;169:511–9.
   Google Scholar
• Radice GL, Ferreira-Cornwell MC, Robinson SD, Rayburn H, Chodosh LA, Takeichi M, . Precocious mammary gland development in P-cadherin-deficient mice. J Cell Biol. 1997;139:1025–32.
   PubMed Web of Science ®Google Scholar
• Srinivasan K, Strickland P, Valdes A, Shin GC, Hinck L. Netrin-1/neogenin interaction stabilizes multipotent progenitor cap cells during mammary gland morphogenesis. Dev Cell. 2003;4:371–82.
   PubMed Web of Science ®Google Scholar
• Morris JS, Stein T, Pringle MA, Davies CR, Weber-Hall S, Ferrier RK, . Involvement of axonal guidance proteins and their signaling partners in the developing mouse mammary gland. J Cellular Physiol. 2006;206:16–24.
   Google Scholar
• Yant J, Buluwela L, Niranjan B, Gusterson B, Kamalati T. In vivo effects of hepatocyte growth factor/scatter factor on mouse mammary gland development. Exp Cell Res. 1998; 241:476–81.
   Google Scholar
• Yi ES, Bedoya AA, Lee H, Kim S, Housley RM, Aukerman SL, . Keratinocyte growth factor causes cystic dilation of the mammary glands of mice. Interactions of keratinocyte growth factor, estrogen, and progesterone in vivo. Am J Pathol. 1994;145:1015–22.
   Google Scholar
• Lu P, Ewald AJ, Martin GR, Werb Z. Genetic mosaic analysis reveals FGF receptor 2 function in terminal end buds during mammary gland branching morphogenesis. Dev Biol. 2008;321:77–87.
   PubMedGoogle Scholar
• Kleinberg DL. Early mammary development: growth hormone and IGF-1. J Mammary Gland Biol Neoplasia. 1997; 2:49–57.
   Google Scholar
• Ruan W, Newman CB, Kleinberg DL. Intact and amino-terminally shortened forms of insulin-like growth factor I induce mammary gland differentiation and development. Proc Natl Acad Sci U S A. 1992;89:10872–6.
   Google Scholar
• Bonnette SG, Hadsell DL. Targeted disruption of the IGF-I receptor gene decreases cellular proliferation in mammary terminal end buds. Endocrinology. 2001;142:4937–45.
   PubMedGoogle Scholar
• Allar MA, Wood TL. Expression of the insulin-like growth factor binding proteins during postnatal development of the murine mammary gland. Endocrinology. 2004;145:2467–77.
   PubMedGoogle Scholar
• Asselin-Labat ML, Sutherland KD, Barker H, Thomas R, Shackleton M, Forrest NC, . Gata-3 is an essential regulator of mammary-gland morphogenesis and luminal-cell differentiation. Nat Cell Biol. 2007;9:201–9.
   PubMed Web of Science ®Google Scholar
• Kouros-Mehr H, Slorach EM, Sternlicht MD, Werb Z. GATA-3 maintains the differentiation of the luminal cell fate in the mammary gland. Cell. 2006;127:1041–55.
   PubMed Web of Science ®Google Scholar
• Humphreys RC, Krajewska M, Krnacik S, Jaeger R, Weiher H, Krajewski S, . Apoptosis in the terminal endbud of the murine mammary gland: a mechanism of ductal morphogenesis. Development. 1996;122:4013–22.
   PubMedGoogle Scholar
• Mailleux AA, Overholtzer M, Schmelzle T, Bouillet P, Strasser A, Brugge JS. BIM regulates apoptosis during mammary ductal morphogenesis, and its absence reveals alternative cell death mechanisms. Dev Cell. 2007;12:221–34.
   PubMed Web of Science ®Google Scholar
• Nelson CM, Vanduijn MM, Inman JL, Fletcher DA, Bissell MJ. Tissue geometry determines sites of mammary branching morphogenesis in organotypic cultures. Science. 2006; 314:298–300.
   PubMed Web of Science ®Google Scholar
• Joseph H, Gorska AE, Sohn P, Moses HL, Serra R. Overexpression of a kinase-deficient transforming growth factor-beta type II receptor in mouse mammary stroma results in increased epithelial branching. Mol Biology Cell. 1999;10: 1221–34.
   PubMedGoogle Scholar
• Kamalati T, Niranjan B, Yant J, Buluwela L. HGF/SF in mammary epithelial growth and morphogenesis: in vitro and in vivo models. J Mammary Gland Biol Neoplasia. 1999;4: 69–77.
   Google Scholar
• Niranjan B, Buluwela L, Yant J, Perusinghe N, Atherton A, Phippard D, . HGF/SF: a potent cytokine for mammary growth, morphogenesis and development. Development. 1995;121:2897–908.
   PubMed Web of Science ®Google Scholar
• Soriano JV, Pepper MS, Orci L, Montesano R. Roles of hepatocyte growth factor/scatter factor and transforming growth factor-beta1 in mammary gland ductal morphogenesis. J Mammary Gland Biol Neoplasia. 1998;3: 133–50.
   Google Scholar
• Pollard JW. Tumour-stromal interactions. Transforming growth factor-beta isoforms and hepatocyte growth factor/scatter factor in mammary gland ductal morphogenesis. Breast Cancer Res. 2001;3:230–7.
   PubMed Web of Science ®Google Scholar
• Soriano JV, Pepper MS, Nakamura T, Orci L, Montesano R. Hepatocyte growth factor stimulates extensive development of branching duct-like structures by cloned mammary gland epithelial cells. J Cell Sci. 1995;108(Pt 2):413–30.
   Google Scholar
• Berdichevsky F, Alford D, D'Souza B, Taylor-Papadimitriou J. Branching morphogenesis of human mammary epithelial cells in collagen gels. J Cell Sci. 1994;107 (Pt 12):3557–68.
   Google Scholar
• Alford D, Baeckstrom D, Geyp M, Pitha P, Taylor-Papadimitriou J. Integrin-matrix interactions affect the form of the structures developing from human mammary epithelial cells in collagen or fibrin gels. J Cell Sci. 1998;111 (Pt 4):521–32.
   Google Scholar
• Brisken C, Heineman A, Chavarria T, Elenbaas B, Tan J, Dey SK, . Essential function of Wnt-4 in mammary gland development downstream of progesterone signaling. Genes Dev. 2000;14:650–4.
   PubMed Web of Science ®Google Scholar
• Creamer BA, Sakamoto K, Schmidt JW, Triplett AA, Moriggl R, Wagner KU. Stat5 promotes survival of mammary epithelial cells through transcriptional activation of a distinct promoter in Akt1. Mol Cell Biol. 2010;30:2957–70.
   PubMedGoogle Scholar
• Lembo G, Rockman HA, Hunter JJ, Steinmetz H, Koch WJ, Ma L, . Elevated blood pressure and enhanced myocardial contractility in mice with severe IGF-1 deficiency. J Clin Invest. 1996;98:2648–55.
   PubMedGoogle Scholar
• Kenney NJ, Bowman A, Korach KS, Barrett JC, Salomon DS. Effect of exogenous epidermal-like growth factors on mammary gland development and differentiation in the estrogen receptor-alpha knockout (ERKO) mouse. Breast Cancer Res Treat. 2003;79:161–73.
   Google Scholar
• Shioda T, Lechleider RJ, Dunwoodie SL, Li H, Yahata T, de Caestecker MP, . Transcriptional activating activity of Smad4: roles of SMAD hetero-oligomerization and enhancement by an associating transactivator. Proc Natl Acad Sci U S A. 1998;95:9785–90.
   PubMedGoogle Scholar
• Ewan KB, Oketch-Rabah HA, Ravani SA, Shyamala G, Moses HL, Barcellos-Hoff MH. Proliferation of estrogen receptor-alpha-positive mammary epithelial cells is restrained by transforming growth factor-beta1 in adult mice. Am J Pathol. 2005;167:409–17.
   PubMedGoogle Scholar
• Andrechek ER, White D, Muller WJ. Targeted disruption of ErbB2/Neu in the mammary epithelium results in impaired ductal outgrowth. Oncogene. 2005;24:932–7.
   PubMedGoogle Scholar
• Wiseman BS, Sternlicht MD, Lund LR, Alexander CM, Mott J, Bissell MJ, . Site-specific inductive and inhibitory activities of MMP-2 and MMP-3 orchestrate mammary gland branching morphogenesis. J Cell Biol. 2003;162:1123–33.
   Google Scholar
• Deome KB, Faulkin LJ Jr, Bern HA, Blair PB. Development of mammary tumors from hyperplastic alveolar nodules transplanted into gland-free mammary fat pads of female C3H mice. Cancer Res. 1959;19:515–20.
   PubMed Web of Science ®Google Scholar
• Smith GH. Experimental mammary epithelial morphogenesis in an in vivo model: evidence for distinct cellular progenitors of the ductal and lobular phenotype. Breast Cancer Res Treat. 1996;39:21–31.
   PubMedGoogle Scholar
• Kordon EC, Smith GH. An entire functional mammary gland may comprise the progeny from a single cell. Development. 1998;125:1921–30.
   PubMed Web of Science ®Google Scholar
• Chepko G, Smith GH. Three division-competent, structurally-distinct cell populations contribute to murine mammary epithelial renewal. Tissue Cell. 1997;29:239–53.
   Google Scholar
• Kordon EC, Smith GH, Callahan R, Gallahan D. A novel non-mouse mammary tumor virus activation of the Int-3 gene in a spontaneous mouse mammary tumor. J Virol. 1995;69:8066–9.
   Google Scholar
• Wainscoat JS, Fey MF. Assessment of clonality in human tumors: a review. Cancer Res. 1990;50:1355–60.
   PubMed Web of Science ®Google Scholar
• Shackleton M, Vaillant F, Simpson KJ, Stingl J, Smyth GK, Asselin-Labat ML, . Generation of a functional mammary gland from a single stem cell. Nature. 2006;439:84–8.
   PubMed Web of Science ®Google Scholar
• Zeps N, Dawkins HJ, Papadimitriou JM, Redmond SL, Walters MI. Detection of a population of long-lived cells in mammary epithelium of the mouse. Cell Tissue Res. 1996; 286:525–36.
   Google Scholar
• Stingl J, Eirew P, Ricketson I, Shackleton M, Vaillant F, Choi D, . Purification and unique properties of mammary epithelial stem cells. Nature. 2006;439:993–7.
   PubMed Web of Science ®Google Scholar
• Williams JM, Daniel CW. Mammary ductal elongation: differentiation of myoepithelium and basal lamina during branching morphogenesis. Dev Biol. 1983;97:274–90.
   PubMedGoogle Scholar
• Sapino A, Macri L, Gugliotta P, Pacchioni D, Liu YJ, Medina D, . Immunophenotypic properties and estrogen dependency of budding cell structures in the developing mouse mammary gland. Differentiation. 1993;55:13–18.
   Google Scholar
• Kurpios NA, MacNeil L, Shepherd TG, Gludish DW, Giacomelli AO, Hassell JA. The Pea3 Ets transcription factor regulates differentiation of multipotent progenitor cells during mammary gland development. Dev Biol. 2009; 325:106–21.
   Google Scholar
• Benz CC, O'Hagan RC, Richter B, Scott GK, Chang CH, Xiong X, . HER2/Neu and the Ets transcription activator PEA3 are coordinately upregulated in human breast cancer. Oncogene. 1997;15:1513–25.
   PubMed Web of Science ®Google Scholar
• Jiang P, Hu Q, Ito M, Meyer S, Waltz S, Khan S, . Key roles for MED1 LxxLL motifs in pubertal mammary gland development and luminal-cell differentiation. Proc Natl Acad Sci U S A. 2010;107:6765–70.
   PubMed Web of Science ®Google Scholar
• Latres E, Malumbres M, Sotillo R, Martin J, Ortega S, Martin-Caballero J, . Limited overlapping roles of P15(INK4b) and P18(INK4c) cell cycle inhibitors in proliferation and tumorigenesis. EMBO J. 2000;19:3496–506.
   PubMed Web of Science ®Google Scholar
• Kouros-Mehr H, Bechis SK, Slorach EM, Littlepage LE, Egeblad M, Ewald AJ, . GATA-3 links tumor differentiation and dissemination in a luminal breast cancer model. Cancer cell. 2008;13:141–52.
   PubMedGoogle Scholar
• Eeckhoute J, Keeton EK, Lupien M, Krum SA, Carroll JS, Brown M. Positive cross-regulatory loop ties GATA-3 to estrogen receptor alpha expression in breast cancer. Cancer Res. 2007;67:6477–83.
   PubMed Web of Science ®Google Scholar
• van de Vijver MJ, He YD, van't Veer LJ, Dai H, Hart AA, Voskuil DW, . A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med. 2002;347:1999–2009.
   PubMed Web of Science ®Google Scholar
• Pei XH, Bai F, Smith MD, Usary J, Fan C, Pai SY, . CDK inhibitor p18(INK4c) is a downstream target of GATA3 and restrains mammary luminal progenitor cell proliferation and tumorigenesis. Cancer cell. 2009;15:389–401.
   PubMed Web of Science ®Google Scholar
• Althuis MD, Fergenbaum JH, Garcia-Closas M, Brinton LA, Madigan MP, Sherman ME. Etiology of hormone receptor-defined breast cancer: a systematic review of the literature. Cancer Epidemiol Biomarkers Prev. 2004;13:1558–68.
   PubMed Web of Science ®Google Scholar
• Sparmann A, van Lohuizen M. Polycomb silencers control cell fate, development and cancer. Nat Rev Cancer. 2006; 6:846–56.
   PubMed Web of Science ®Google Scholar
• van der Lugt NM, Domen J, Linders K, van Roon M, Robanus-Maandag E, te Riele H, . Posterior transformation, neurological abnormalities, and severe hematopoietic defects in mice with a targeted deletion of the bmi-1 proto-oncogene. Genes Dev. 1994;8:757–69.
   PubMed Web of Science ®Google Scholar
• Park IK, Qian D, Kiel M, Becker MW, Pihalja M, Weissman IL, . Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells. Nature. 2003;423:302–5.
   PubMed Web of Science ®Google Scholar
• Molofsky AV, Pardal R, Iwashita T, Park IK, Clarke MF, Morrison SJ. Bmi-1 dependence distinguishes neural stem cell self-renewal from progenitor proliferation. Nature. 2003;425:962–7.
   PubMed Web of Science ®Google Scholar
• Pietersen AM, Evers B, Prasad AA, Tanger E, Cornelissen-Steijger P, Jonkers J, van Lohuizen M. Bmi1 regulates stem cells and proliferation and differentiation of committed cells in mammary epithelium. Curr Biol. 2008;18:1094–9.
   PubMed Web of Science ®Google Scholar
• Dontu G, El-Ashry D, Wicha MS. Breast cancer, stem/progenitor cells and the estrogen receptor. Trends Endocrinol Metab. 2004;15:193–7.
   PubMed Web of Science ®Google Scholar
• Asselin-Labat ML, Shackleton M, Stingl J, Vaillant F, Forrest NC, Eaves CJ, . Steroid hormone receptor status of mouse mammary stem cells. J Natl Cancer Inst. 2006;98: 1011–4.
   PubMedGoogle Scholar
• Sleeman KE, Kendrick H, Robertson D, Isacke CM, Ashworth A, Smalley MJ. Dissociation of estrogen receptor expression and in vivo stem cell activity in the mammary gland. J Cell Biol. 2007;176:19–26.
   PubMedGoogle Scholar
• Asselin-Labat ML, Vaillant F, Sheridan JM, Pal B, Wu D, Simpson ER, . Control of mammary stem cell function by steroid hormone signalling. Nature. 2010;465: 798–803.
   PubMed Web of Science ®Google Scholar
• Joshi PA, Jackson HW, Beristain AG, Di Grappa MA, Mote PA, Clarke CL, . Progesterone induces adult mammary stem cell expansion. Nature. 2010;465:803–7.
   PubMed Web of Science ®Google Scholar
• Kenney NJ, Smith GH, Lawrence E, Barrett JC, Salomon DS. Identification of stem cell units in the terminal end bud and duct of the mouse mammary gland. J Biomed Biotechnol. 2001;1:133–43.
   PubMedGoogle Scholar
• Taddei I, Deugnier MA, Faraldo MM, Petit V, Bouvard D, Medina D, . Beta1 integrin deletion from the basal compartment of the mammary epithelium affects stem cells. Nat Cell Biol. 2008;10:716–22.
   PubMed Web of Science ®Google Scholar
• Deugnier MA, Faraldo MM, Teuliere J, Thiery JP, Medina D, Glukhova MA. Isolation of mouse mammary epithelial progenitor cells with basal characteristics from the Comma-Dbeta cell line. Dev Biol. 2006;293:414–25.
   PubMedGoogle Scholar
• Danielson KG, Oborn CJ, Durban EM, Butel JS, Medina D. Epithelial mouse mammary cell line exhibiting normal morphogenesis in vivo and functional differentiation in vitro. Proc Natl Acad Sci U S A. 1984;81:3756–60.
   PubMedGoogle Scholar
• Booth BW, Boulanger CA, Anderson LH, Jimenez-Rojo L, Brisken C, Smith GH. Amphiregulin mediates self-renewal in an immortal mammary epithelial cell line with stem cell characteristics. Exp Cell Res. 2010;316:422–32.
   PubMed Web of Science ®Google Scholar
• McBryan J, Howlin J, Kenny PA, Shioda T, Martin F. ERalpha-CITED1 co-regulated genes expressed during pubertal mammary gland development: implications for breast cancer prognosis. Oncogene. 2007;26:6406–19.
   Google Scholar
• Gouon-Evans V, Rothenberg ME, Pollard JW. Postnatal mammary gland development requires macrophages and eosinophils. Development. 2000;127:2269–82.
   PubMed Web of Science ®Google Scholar
• Li W, Ferguson BJ, Khaled WT, Tevendale M, Stingl J, Poli V, . PML depletion disrupts normal mammary gland development and skews the composition of the mammary luminal cell progenitor pool. Proc Natl Acad Sci U S A. 2009;106:4725–30.
   Google Scholar
• Kariagina A, Aupperlee MD, Haslam SZ. Progesterone receptor isoform functions in normal breast development and breast cancer. Crit Rev Eukaryot Gene Expr. 2008;18:11–33.
   PubMed Web of Science ®Google Scholar
• LeRoith D. Clinical relevance of systemic and local IGF-I: lessons from animal models. Pediatr Endocrinol Rev. 2008;5 Suppl 2:739–43.
   Google Scholar
• Falls DL. Neuregulins: functions, forms, and signaling strategies. Exp Cell Res. 2003;284:14–30.
   PubMed Web of Science ®Google Scholar
• Stern DF. ERBB3/HER3 and ERBB2/HER2 duet in mammary development and breast cancer. J Mammary Gland Biol Neoplasia. 2008;13:215–23.
   PubMed Web of Science ®Google Scholar
• Schwertfeger KL, Rosen JM, Cohen DA. Mammary gland macrophages: pleiotropic functions in mammary development. J Mammary Gland Biol Neoplasia. 2006;11:229–38.
   PubMed Web of Science ®Google Scholar
• Whyte J, Bergin O, Bianchi A, McNally S, Martin F. Key signalling nodes in mammary gland development and cancer. Mitogen-activated protein kinase signalling in experimental models of breast cancer progression and in mammary gland development. Breast Cancer Res. 2009;11:209.
   PubMed Web of Science ®Google Scholar